In order to investigate the relation of weight loss and intravenous hyperalimentation therapy to low T
3 syndrome, serum T
3, T
4. rT
3 and TBG were determined by radioimmunoassay in 105 cancer patients.
The cancer patients were classified into 3 groups, Group I, II and III depending on the grade of weight loss, ranging up to a 5% change in weight loss from a healthy condition, from 5 to 9%, and more than 10%, respectively. Cancer patients under age 59 showed no significant difference in serum T
3, T
4, rT
3 and TBG among these 3 groups. However serum T
3 and T
3/T
4 in cancer patients at age 60 and over were significantly reduced in group III, compared to groups I and II. Serum rT
3 values were significantly elevated in group III of elderly cancer patients. The incidence of low T
3 syndrome in group III of elderly cancer patients was also significantly higher than in groups I and II.
In three out of 5 cancer patients with low T
3 syndrome, serum T
3 values increased after the intravenous hyperalimentation therapy, whereas no significant change in serum T
3 values was observed in two patients who died within one day after the final examination.
It is concluded that weight loss produced different effects on peripheral conversion of T
4 to T
3 between cancer patients under age 59 and over age 60 and glucose plays an important role in the pathogenesis of low T
3 syndrome except cases with very poor prognosis.
View full abstract